PGI2as a Regulator of Inflammatory Diseases
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Prostacyclin, or PGI 2, is an end product derived from the sequential metabolism of arachidonic acid via cyclooxygenase and PGI synthase (PGIS). The receptor for PGI 2, IP, can be found on a variety of cell types and signaling through this receptor exhibits broad physiological effects. Historically, PGI 2 has been understood to play a role in cardiovascular health, specifically having powerful vasodilatory effects via relaxation of smooth muscle and inhibiting of platelet aggregation. For these reasons, PGI 2 has a long history of use for the treatment of pulmonary arterial hypertension (PAH). Only recently, its importance as an immunomodulatory agent has been investigated. PGI 2 regulates both the innate and adaptive immune systems and its effects are, for the most part, thought to be anti-inflammatory or immunosuppressive in nature, which may have implications for its further clinical use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Needleman, P., Moncada, S., Bunting, S., Vane, J. R., Hamberg, M., & Samuelsson, B. (1976) · Nature · doi:10.1038/261558a0 · Cited by 526 · cited 1×
“Prostacyclin, or PGI2, was first reported by Needleman and Vane in 1976 and is an end product derived from the sequential metabolism of arachidonic acid via cyclooxygenase2 (COX-2) and prostacyclin synthase (PGIS) [1].”
BackgroundCOX-2-Derived Prostacyclin Confers Atheroprotection on Female Mice
Egan, K. M., Lawson, J. A., Fries, S., Koller, B., Rader, D. J., Smyth, E. M., & FitzGerald, G. A. (2004) · Science · doi:10.1126/science.1103333 · Cited by 431
Dahlén, S. E., Hansson, G., Hedqvist, P., Björck, T., Granström, E., & Dahlén, B. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.6.1712 · Cited by 415
Zou, M., Martin, C., & Ullrich, V. (1997) · Biological Chemistry · doi:10.1515/bchm.1997.378.7.707 · Cited by 289 · cited 1×
“Production of PGI2 is decreased by the inhibition of PGIS by tyrosine-nitrating agents such as peroxynitrite [11] and tetranitromethane [12].”
BackgroundZou, M.-H., & Ullrich, V. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00160-3 · Cited by 231 · cited 1×
“Production of PGI2 is decreased by the inhibition of PGIS by tyrosine-nitrating agents such as peroxynitrite [11] and tetranitromethane [12].”
BackgroundHonda, T., Segi-Nishida, E., Miyachi, Y., & Narumiya, S. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051310 · Cited by 208
Zhou, W., Hashimoto, K., Goleniewska, K., O’Neal, J. F., Ji, S., Blackwell, T. S., FitzGerald, G. A., Egan, K. M., Geraci, M. W., & Peebles, R. S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.2.702 · Cited by 165
Self-citationSchulman, E. S., Newball, H. H., Demers, L. M., Fitzpatrick, F. A., & Adkinson, N. F. (1981) · PubMed · doi:10.1164/arrd.1981.124.4.402 · Cited by 163
Prostacyclin Prevents Pulmonary Endothelial Cell Apoptosis Induced by Cigarette Smoke
Nana-Sinkam, S. P., Lee, J. D., Sotto-Santiago, S. M., Stearman, R. S., Keith, R. L., Choudhury, Q. G., Cool, C. D., Parr, J. E., Moore, M. D., Bull, T. M., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200605-724oc · Cited by 140 · cited 12×
“PGI2 has a long history of use for the treatment of pulmonary arterial hypertension (PAH) [14, 16, 28].”
BackgroundInfluentialProstacyclin: A Vascular Mediator
Vane, J. R., & Corin, R. E. (2003) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/s1078-5884(03)00385-x · Cited by 138 · cited 1×
“It is hypothesized that early depletion of PGI2 from endothelial tissue could lead to the pathogenesis of atherosclerosis by causing deposition of adipocyte lipid in smooth muscle cells [26].”
Background
Cited by
Resolution of inflammation in bone regeneration: From understandings to therapeutic applications
Newman, H., Shih, Y. V., & Varghese, S. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121114 · Cited by 313
Proinflammatory Pathways: The Modulation by Flavonoids
Ribeiro, D., Freitas, M., Lima, J. L. F. C., & Fernandes, E. (2015) · Medicinal Research Reviews · doi:10.1002/med.21347 · Cited by 147
Metadata
- Authors
- Dorris, S. L., & Peebles, R. S.
- Venue
- Mediators of Inflammation
- Publisher
- Wiley
- Published
- 2012
- Volume
- 2012
- Pages
- 1-9
- ISSN
- 0962-9351 (ISSN-L)
- 1466-1861
- OpenAlex
- W2068594714
- Cited by
- 166
- References
- 44
- FWCI
- 4.54
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PGI2as a Regulator of Inflammatory Diseases. https://app.cochat.ai/papers/10.1155/2012/926968
- The paper
- Dorris, S. L., & Peebles, R. S. (2012). PGI2as a Regulator of Inflammatory Diseases. Mediators of Inflammation. https://doi.org/10.1155/2012/926968
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.